As was stated on the Charts thread, the Director sell off (despite the forward knowledge of the informed market know they would once the technically hit the production milestones) has changed momentum to the downside and under the daily MAs.
People would do well to understand momentum thematics and how they are related to any volatile market asset. A bit of Newton's First Law of Motion... The Director sell halted and inverted momentum (along with the current flat U price), that was established as a result of the Uranium supply demand narrative + management hitting their milestones... price moved ahead of the curve and now is being balanced out.
Momentum is unlikely to settle until something (or a multitude of things) of similar magnitude as the Director sell materializes.
BOE is being shorted and is at risk of a gap down or two.
The scenario @Alex.shipway is superimposing, is normal. Its not just fundamentals that drive a market's behaviour, its human behaviour, which is often irrational and culminates in blow off tops and gap down bear spikes. Its a Bear.
- Forums
- ASX - By Stock
- BOE
- Uninvestable
Uninvestable, page-67
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOE (ASX) to my watchlist
|
|||||
Last
$2.95 |
Change
0.010(0.34%) |
Mkt cap ! $1.208B |
Open | High | Low | Value | Volume |
$2.98 | $2.98 | $2.89 | $6.904M | 2.353M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 13250 | $2.94 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.96 | 19432 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 13250 | 2.940 |
2 | 47643 | 2.930 |
4 | 61484 | 2.920 |
4 | 32952 | 2.910 |
5 | 37580 | 2.900 |
Price($) | Vol. | No. |
---|---|---|
2.960 | 19432 | 4 |
2.970 | 26372 | 4 |
2.980 | 35454 | 4 |
2.990 | 28653 | 6 |
3.000 | 18002 | 2 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
BOE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online